Skip to main content
. Author manuscript; available in PMC: 2023 Dec 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2022 Dec 15;91(5):460–468. doi: 10.1097/QAI.0000000000003082

Table 4.

Adjusted Odds Ratios (OR)* and 95% Confidence Intervals (CI) for INH adherence <90% in the prior 3 months (n = 539 observations; n = 279 participants) – stratified by social desirability score at baseline.

Low/moderate SDSx High SDS x x
Adjusted OR (95% CI) p-value Adjusted OR (95% CI) p-value
Alcohol use**, prior 3 months 0.03 0.04
None 1.00 1.00
Moderate 1.81 (0.81, 4.06) 1.37 (0.65, 2.86)
Unhealthy 3.03 (1.33, 6.94) 2.60 (1.22, 5.54)
Age (per 1 year decrease) 1.04 (1.00, 1.07) 0.04 1.06 (1.01, 1.10) 0.01
Gender 0.58 0.54
Female 1.00 1.00
Male 1.21 (0.62, 2.38) 1.27 (0.59, 2.76)
Depression 0.51 0.64
No 1.00 1.00
Yes 1.30 (0.59, 2.87) 1.76 (0.16, 19.12)
Grade 2+ LEEs or symptomsα 0.47 0.21
No 1.00 1.00
Yes 1.29 (0.64, 2.63) 1.61 (0.77, 3.37)
Low social support 0.75 0.60
No 1.00 1.00
Yes 0.90 (0.47, 1.73) 0.81 (0.38, 1.76)
ART adherence, prior 30 days 0.02 0.01
Good/fair/poor/very poor 2.41 (1.13, 5.15) 2.47 (1.21, 5.05)
Excellent/very good 1.00 1.00
Study visit <0.01 <0.01
3 months 1.00 1.00
6 months 1.96 (1.27, 3.01) 1.76 (1.17, 2.66)
*

GEE logistic regression models, exchangeable working correlation with robust empirical std errors

x

n = 271 observations; n = 141 participants

x x

n = 268 observations; n = 138 participants

**

Alcohol use: None: no self-report, PEth < 8; Moderate: any self-report but AUDIT-C negative; 8 <= PEth < 50; Unhealthy: AUDIT-C positive or PEth >= 50

α

Grade 2 or higher symptoms or liver enzyme elevations (LEEs) ≥2x upper limit of normal, in the prior 3 months